Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status
Crossref DOI link: https://doi.org/10.1007/s13277-016-4899-z
Published Online: 2016-01-30
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yoon, Ghilsuk
Lee, Hwayoung
Kim, Jae-Hoon
Hur, Keun
Seo, An Na
Text and Data Mining valid from 2016-01-30